Assignee
PFIZER
US4,152 patents
Top patents by PatentIndex Score
US7449616B2Nov 11, 2008
Anti-NGF antibodies and methods using same
PFIZER93 citations99
US7288251B2Oct 30, 2007
Antibodies to CD40
PFIZER158 citations99
US6627754B2Sep 30, 2003
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER103 citations99
US6603008B1Aug 5, 2003
Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents
PFIZER600 citations99
US6235764B1May 22, 2001
Isothiazole derivatives useful as anticancer agents
PFIZER261 citations99
US5863949AJan 26, 1999
Arylsulfonylamino hydroxamic acid derivatives
PFIZER528 citations99
US5834450ANov 10, 1998
9- (substituted amino) -alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
PFIZER252 citations99
US5552412ASep 3, 1996
5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
PFIZER194 citations99
US5516527AMay 14, 1996
Dispensing device powered by hydrogel
PFIZER202 citations99
US5514138AMay 7, 1996
Connector having a stop member
PFIZER169 citations99
US5306726AApr 26, 1994
3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
PFIZER112 citations99
US4831031AMay 16, 1989
Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
PFIZER307 citations99
US4572909AFeb 25, 1986
2-(Secondary aminoalkoxymethyl) dihydropyridine derivatives as anti-ischaemic and antihypertensive agents
PFIZER241 citations99
US4474768AOct 2, 1984
N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
PFIZER246 citations99
US7655232B2Feb 2, 2010
Anti-NGF antibodies and methods using same
PFIZER60 citations98
US7199123B2Apr 3, 2007
Pyrazine compounds as transforming growth factor (TGF) compounds
PFIZER59 citations98
US7132281B2Nov 7, 2006
Methods and host cells for producing human monoclonal antibodies to CTLA-4
PFIZER220 citations98
US7125880B1Oct 24, 2006
Corticotropin releasing factor antagonists
PFIZER97 citations98
US7109003B2Sep 19, 2006
Methods for expressing and recovering human monoclonal antibodies to CTLA-4
PFIZER287 citations98
US6962993B2Nov 8, 2005
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER68 citations98
US6706283B1Mar 16, 2004
Controlled release by extrusion of solid amorphous dispersions of drugs
PFIZER202 citations98
US6635762B1Oct 21, 2003
Monocyclic-7H-pyrrolo[2,3-d]pyrimidine compounds, compositions, and methods of use
PFIZER151 citations98
US6410550B1Jun 25, 2002
Aryl fused azapolycyclic compounds
PFIZER134 citations98
US6337332B1Jan 8, 2002
Neuropeptide Y receptor antagonists
PFIZER107 citations98
US6197786B1Mar 6, 2001
4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
PFIZER155 citations98
US6194454B1Feb 27, 2001
Cyano containing oxamic acids and derivatives as thyroid receptor ligands
PFIZER147 citations98
US6140343AOct 31, 2000
4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
PFIZER174 citations98
US6071935AJun 6, 2000
Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors
PFIZER106 citations98
US6001860ADec 14, 1999
N-aryl and N-heteroarylurea derivatives as inhibitors of acyl coenzyme A: Cholesterol acyl transferase (ACAT)
PFIZER91 citations98
US5998463ADec 7, 1999
Glycogen phosphorylase inhibitors
PFIZER98 citations98
US5861510AJan 19, 1999
Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors
PFIZER536 citations98
US5719283AFeb 17, 1998
Intermediates useful in the synthesis of pyrazolopyrimidinone antianginal agents
PFIZER120 citations98
US5698220ADec 16, 1997
Asymmetric membranes in delivery devices
PFIZER264 citations98
US5639757AJun 17, 1997
4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors
PFIZER119 citations98
US5612059AMar 18, 1997
Use of asymmetric membranes in delivery devices
PFIZER270 citations98
US5593997AJan 14, 1997
4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
PFIZER355 citations98
US5553613ASep 10, 1996
Non invasive blood analyte sensor
PFIZER117 citations98
US5443843AAug 22, 1995
Gastric retention system for controlled drug release
PFIZER208 citations98
US5431921AJul 11, 1995
Dispensing device containing a hydrophobic medium
PFIZER834 citations98
US5387584AFeb 7, 1995
Bicyclic ansamycins
PFIZER130 citations98
US5346901ASep 13, 1994
Pyrazolopyrimidinone antianginal agents
PFIZER119 citations98
US5250534AOct 5, 1993
Pyrazolopyrimidinone antianginal agents
PFIZER276 citations98
US5232929AAug 3, 1993
3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
PFIZER126 citations98
US4896661AJan 30, 1990
Multi purpose orthopedic ratcheting forceps
PFIZER322 citations98
US4895724AJan 23, 1990
Chitosan compositions for controlled and prolonged release of macromolecules
PFIZER250 citations98
US4803076AFeb 7, 1989
Controlled release device for an active substance
PFIZER238 citations98
US4599198AJul 8, 1986
Intermediates in polypeptide synthesis
PFIZER210 citations98
US4536518AAug 20, 1985
Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
PFIZER278 citations98
US10590087B1Mar 17, 2020
Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
PFIZER39 citations97
US10208019B2Feb 19, 2019
GLP-1 receptor agonists and uses thereof
PFIZER50 citations97
Showing the top 50 of 4,152 patents by PatentIndex Score.